99 related articles for article (PubMed ID: 9215799)
1. Impaired cellular cholesterol efflux by oxysterol-enriched high density lipoproteins.
Gesquière L; Loreau N; Blache D
Free Radic Biol Med; 1997; 23(4):541-7. PubMed ID: 9215799
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages.
Rifici VA; Khachadurian AK
Biochim Biophys Acta; 1996 Jan; 1299(1):87-94. PubMed ID: 8555257
[TBL] [Abstract][Full Text] [Related]
3. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages.
Pirillo A; Uboldi P; Kuhn H; Catapano AL
Biochim Biophys Acta; 2006 Mar; 1761(3):292-300. PubMed ID: 16647293
[TBL] [Abstract][Full Text] [Related]
4. THP1 macrophages oxidized cholesterol, generating 7-derivative oxysterols specifically released by HDL.
Chen Y; Arnal-Levron M; Lagarde M; Moulin P; Luquain-Costaz C; Delton I
Steroids; 2015 Jul; 99(Pt B):212-8. PubMed ID: 25742736
[TBL] [Abstract][Full Text] [Related]
5. Binding of modified high density lipoproteins to endothelial cells: relation with cellular cholesterol efflux?
Kilsdonk EP; van Gent T; Dorsman AN; van Tol A
Atherosclerosis; 1992 Dec; 97(2-3):131-42. PubMed ID: 1466659
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux.
Rifici VA; Khachadurian AK
Atherosclerosis; 1996 Nov; 127(1):19-26. PubMed ID: 9006800
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells.
Cogny A; Atger V; Paul JL; Soni T; Moatti N
Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):285-92. PubMed ID: 8660296
[TBL] [Abstract][Full Text] [Related]
8. Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts.
Salmon S; Mazière C; Auclair M; Theron L; Santus R; Mazière JC
Biochim Biophys Acta; 1992 Apr; 1125(2):230-5. PubMed ID: 1571368
[TBL] [Abstract][Full Text] [Related]
9. [The modification of high density lipoproteins by malondialdehyde changes their interaction with J774 macrophages and decreases cholesterol cell efflux].
Salmon S; Mazière JC; Mazière C; Auclair M; Santus R; Polonovski J
C R Seances Soc Biol Fil; 1990; 184(2):105-13. PubMed ID: 2148897
[TBL] [Abstract][Full Text] [Related]
10. Reduced cholesterol efflux to mildly oxidized high density lipoprotein.
Morel DW
Biochem Biophys Res Commun; 1994 Apr; 200(1):408-16. PubMed ID: 8166713
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol.
Kilsdonk EP; Morel DW; Johnson WJ; Rothblat GH
J Lipid Res; 1995 Mar; 36(3):505-16. PubMed ID: 7775862
[TBL] [Abstract][Full Text] [Related]
12. Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages.
Dory L
J Lipid Res; 1991 May; 32(5):783-92. PubMed ID: 2072040
[TBL] [Abstract][Full Text] [Related]
13. Oleic acid rich diet protects against the oxidative modification of high density lipoprotein.
Solà R; La Ville AE; Richard JL; Motta C; Bargalló MT; Girona J; Masana L; Jacotot B
Free Radic Biol Med; 1997; 22(6):1037-45. PubMed ID: 9034243
[TBL] [Abstract][Full Text] [Related]
14. High density lipoprotein 3 inhibits oxidized low density lipoprotein-induced apoptosis via promoting cholesterol efflux in RAW264.7 cells.
Jiang P; Yan PK; Chen JX; Zhu BY; Lei XY; Yin WD; Liao DF
Acta Pharmacol Sin; 2006 Feb; 27(2):151-7. PubMed ID: 16412263
[TBL] [Abstract][Full Text] [Related]
15. In vitro oxidized HDL and HDL from type 2 diabetes patients have reduced ability to efflux oxysterols from THP-1 macrophages.
Chen Y; Arnal-Levron M; Hullin-Matsuda F; Knibbe C; Moulin P; Luquain-Costaz C; Delton I
Biochimie; 2018 Oct; 153():232-237. PubMed ID: 29704538
[TBL] [Abstract][Full Text] [Related]
16. Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages.
Bergt C; Reicher H; Malle E; Sattler W
FEBS Lett; 1999 Jun; 452(3):295-300. PubMed ID: 10386609
[TBL] [Abstract][Full Text] [Related]
17. Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity.
Rashduni DL; Rifici VA; Schneider SH; Khachadurian AK
Metabolism; 1999 Feb; 48(2):139-43. PubMed ID: 10024072
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1.
Terasaka N; Wang N; Yvan-Charvet L; Tall AR
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15093-8. PubMed ID: 17846428
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
20. Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux.
Pirillo A; Uboldi P; Pappalardo G; Kuhn H; Catapano AL
Cardiovasc Res; 2007 Aug; 75(3):566-74. PubMed ID: 17524375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
